Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-25-116430·CASI Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
CASI PHARMACEUTICALS INC
Ordinary Share · CUSIP: G1933S101
Event date: 2025-09-30
- Filing-level shares
- 2,255,636.00
- Percent of class
- 11.0%
- Chen Zhenfeng
Shares: 2,255,636.00 · Class: 11.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-116430
- Form type
- SCHEDULE 13G
- Filer
- CASI Pharmaceuticals, Inc.
- CIK
- CIK 1962738
- Filed
- Nov 26, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership